Clinical Research, Pharma & Healthcare FinancingENCell’s EN001 Gets FDA Orphan Drug Designation for CMTBusiness WireMarch 7, 2025March 10, 2025 by Business WireMarch 7, 2025March 10, 2025053 ENCell, a leading biopharmaceutical company for cell and gene therapy CDMO and novel drug development, announced today that its investigational drug EN001 has been granted...
